Range Low Price High Price Comment
30 days $3.76 $3.76 Friday, 27th May 2022 CHMA stock ended at $3.76. During the day the stock fluctuated 0% from a day low at $3.76 to a day high of $3.76.
90 days $3.76 $3.76
52 weeks $3.76 $4.93

Historical Chiasma prices

Date Open High Low Close Volume
Jan 22, 2016 $10.00 $10.00 $9.33 $9.46 130 000
Jan 21, 2016 $10.19 $10.51 $9.65 $9.78 220 600
Jan 20, 2016 $11.00 $11.06 $9.71 $10.19 322 900
Jan 19, 2016 $12.55 $12.55 $10.90 $11.32 187 000
Jan 15, 2016 $11.79 $12.92 $11.48 $12.37 284 900
Jan 14, 2016 $12.91 $12.91 $12.01 $12.24 131 700
Jan 13, 2016 $13.39 $13.97 $12.63 $12.84 118 100
Jan 12, 2016 $13.11 $13.68 $12.66 $13.27 159 500
Jan 11, 2016 $15.53 $15.59 $11.79 $12.98 928 300
Jan 08, 2016 $17.31 $17.33 $15.30 $15.45 214 300
Jan 07, 2016 $17.98 $18.36 $17.06 $17.38 165 500
Jan 06, 2016 $18.92 $19.05 $17.72 $18.35 95 000
Jan 05, 2016 $19.50 $19.71 $18.68 $19.27 63 400
Click to get the best stock tips daily for free!

About Chiasma

Chiasma Chiasma, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing oral forms of therapies for patients suffering from orphan diseases. Its product candidate is octreotide capsules or MYCAPSSA, which has completed Phase III clinical trial for the treatment of acromegaly, a condition that results in the body’s production of excess growth hormone. Chiasma, Inc. was founded in 2001 and is headquartered in Newton, Massa... CHMA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT